Immunotherapy Versus Chemotherapy for Methotrexate-Resistant Low-Risk Gestational Trophoblastic Neoplasia Reply

被引：0
|
作者：
You, Benoit [1 ,2 ,3 ]
Bolze, Pierre-Adrien [1 ,2 ,4 ]
Golfier, Francois [1 ,2 ,4 ]
机构：
[1] Ctr Reference Malad Trophoblast, Lyon, France
[2] Univ Claude Bernard Lyon 1, Univ Lyon, EMR UCBL, HCL 3738, Lyon, France
[3] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Inst Cancerol, Med Oncol,IC HCL,CITOHL, Lyon, France
[4] Hosp Civils Lyon, Serv Chirurg Gynecol & Oncol, Obstet, Ctr Hosp Lyon Sud, Pierre Benite, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 36期
关键词：
PEMBROLIZUMAB; PHASE-3;
D O I：
10.1200/JCO.20.02911
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4350 / +
页数：3
相关论文
共 50 条
  • [21] Treatment of Low-Risk Gestational Trophoblastic Neoplasia
    Aghajanian, Carol
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07) : 786 - +
  • [22] Response to Chemotherapy in Overweight/Obese Patients With Low-Risk Gestational Trophoblastic Neoplasia
    Maesta, Izildinha
    Horowitz, Neil S.
    Goldstein, Donald P.
    Bernstein, Marilyn R.
    Ramirez, Luz Angela C.
    Moulder, Janelle
    Berkowitz, Ross S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (04) : 734 - 740
  • [23] Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
    Sheikhhasani, Shahrzad
    Abdolrazaghnejad, Aghdas
    Mousavi, Azam Sadat
    Akhavan, Setareh
    Zamani, Narges
    Feizabad, Elham
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2023, 14 (01) : 47 - 52
  • [24] Comparison of methotrexate, actinomycin D, and etoposide for treating low-risk gestational trophoblastic neoplasia
    Baptista, Angela M.
    Belfort, Paulo
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 119 (01) : 35 - 38
  • [25] Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia
    Chan, Karen K. L.
    Huang, Yong
    Tam, Kar Fai
    Tse, Ka Yu
    Ngan, Hextan Y. S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (05) : 1282 - 1286
  • [26] Methotrexate for 2000 FIGO low-risk gestational trophoblastic neoplasia patients: efficacy and toxicity
    Chalouhi, Gihad Elias
    Golfier, Francois
    Soignon, Pauline
    Massardier, Jerome
    Guastalla, Jean-Paul
    Trillet-Lenoir, Veronique
    Schott, Anne-Marie
    Raudrant, Daniel
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 200 (06) : 643.e1 - 643.e6
  • [27] Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia
    Gilani, MM
    Yarandi, F
    Eftekhar, Z
    Hanjani, P
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2005, 45 (02): : 161 - 164
  • [28] Combined methotrexate-dactinomycin: An effective therapy for low-risk gestational trophoblastic neoplasia
    Eiriksson, Lua
    Wells, Tiffany
    Steed, Helen
    Schepansky, Alexandra
    Capstick, Valerie
    Hoskins, Paul
    Pike, Judith
    Swenerton, Kenneth
    GYNECOLOGIC ONCOLOGY, 2012, 124 (03) : 553 - 557
  • [29] Optimal management of low-risk gestational trophoblastic neoplasia
    Goldstein, Donald P.
    Berkowitz, Ross S.
    Horowitz, Neil S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (11) : 1293 - 1304
  • [30] Hysterectomy in case of low-risk gestational trophoblastic neoplasia
    Massardier, J.
    Mathe, M.
    Bolze, P. -A.
    Hajri, T.
    Devouassoux-Shisheboran, M.
    Schott, A. -M.
    Lotz, J. -P.
    You, B.
    Golfier, F.
    ONCOLOGIE, 2014, 16 (06) : 285 - 290
12345